Detalhe da pesquisa
1.
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets.
Antimicrob Agents Chemother
; 68(3): e0121023, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319076
2.
Persicamidines-Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses.
Angew Chem Int Ed Engl
; 62(6): e202214595, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422061
3.
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages.
Antimicrob Agents Chemother
; 66(12): e0103222, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346232
4.
Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors.
Angew Chem Int Ed Engl
; 61(52): e202212946, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208117
5.
Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis.
Antimicrob Agents Chemother
; 64(8)2020 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513799
6.
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.
Nat Commun
; 15(1): 1173, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332002
7.
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells.
iScience
; 24(12): 103469, 2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34812415
8.
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.
PLoS One
; 16(8): e0255335, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347801